$BFC Cashflow Statement | Understand Stock

$BFC

$148.73 -$0.01 (0.01%) Close

$BFC Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Cash flows from operating activities:
Net income
Adjustments to reconcile net income to net cash provided by operating activities:
Provision for loan losses
Provision for credit losses
Depreciation and amortization of premises and equipment
Amortization of intangibles
Net accretion of securities
Amortization of stock-based compensation
Accretion of purchase accounting valuations
Net change in deferred loan fees and costs
Expense (benefit) from deferred income taxes
Change in fair value of MSR and other investments
Loss from sale and disposal of premises and equipment
Net (gain) loss on sale of OREO and valuation allowance
Proceeds from sales of mortgage loans
Originations of mortgage loans held for sale
Gain on sales of mortgage loans
Realized (gain) loss on sale of securities available for sale and other investments
Realized loss on sale of securities
Undistributed income of UFS joint venture
Undistributed income of Ansay joint venture
Realized gain on sale of UFS
Undistributed earnings of joint venture
UFS
Ansay
Net earnings on life insurance
Increase in other assets
(Decrease) increase in other liabilities
Net cash provided by operating activities

Cash flows from investing activities, net of effects of business combination:
Maturities, prepayments, and calls
Purchases
Activity in securities available for sale and held to maturity: Sales
Activity in securities available for sale and held to maturity: Maturities, prepayments, and calls
Activity in securities available for sale and held to maturity: Purchases
Proceeds from other investments
Net increase in loans
Proceeds from sale of UFS
Dividends received
UFS
Ansay
Dividends received from UFS
Dividends received from Ansay
Proceeds from sale of OREO
Net purchases of Federal Home Loan Bank ("FHLB") stock
Net (purchase) sales of Federal Home Loan Bank ("FHLB") stock
Net purchases of Federal Reserve Bank ("FRB") stock
Proceeds from life insurance
Proceeds from sale of premises and equipment
Purchases of premises and equipment
Net cash received in business combination
Net cash (used in) provided by investing activities

Cash flows from financing activities, net of effects of business combination:
Net increase (decrease) in deposits
Net decrease in securities sold under repurchase agreements
Proceeds from advances of notes payable
Repayment of notes payable
Proceeds from issuance of subordinated notes
Repayment of subordinated notes
Repayment of junior subordinated debentures
Dividends paid
Proceeds from sales of common stock
Repurchase of common stock
Net cash (used in) provided by financing activities

Net (decrease) increase in cash and cash equivalents
Cash and cash equivalents at beginning of year
Cash and cash equivalents at end of year
Supplemental disclosures of cash flow information:
Cash paid during the year for:
Interest
Income taxes
Supplemental schedule of noncash activities:
Loans transferred to OREO
Closed branch building transferred to OREO
MSR resulting from sale of loans
Amortization of unrealized holding gains on securities transferred from available for sale to held to maturity recognized in other comprehensive income, net of tax
Change in unrealized loss on investment securities available for sale, net of tax
Fair value of assets acquired
Fair value of liabilities assumed
Net assets acquired
Total fair value of assets acquired
Common stock issued in acquisition

Comments